Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;2012(3):449-462.
doi: 10.1002/ejoc.201101228. Epub 2011 Dec 9.

Asymmetric Methods for the Synthesis of Flavanones, Chromanones, and Azaflavanones

Affiliations

Asymmetric Methods for the Synthesis of Flavanones, Chromanones, and Azaflavanones

Antoinette E Nibbs et al. European J Org Chem. 2012 Jan.

Abstract

Flavanones, chromanones, and related structures are privileged natural products that display a wide variety of biological activities. Although flavanoids are abundant in nature, there are a limited number of available general and efficient synthetic methods for accessing molecules of this class in a stereoselective manner. Their structurally simple architectures belie the difficulties involved in installation and maintenance of the stereogenic configuration at the C2 position, which can be sensitive and can undergo epimerization under mildly acidic, basic, and thermal reaction conditions. This review presents the methods currently used to access these related structures. The synthetic methods include manipulation of the flavone/flavanone core, carbon-carbon bond formation, and carbon-heteroatom bond formation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flavanoid nomenclature.
Figure 2
Figure 2
Representative biologically active flavanoid natural products.
Figure 3
Figure 3
General methods for accessing enantio-enriched flavanoids.
Scheme 1
Scheme 1
Base-promoted racemization of enantio-enriched flavanones.
Scheme 2
Scheme 2
Asymmetric hydrogenation of 4-chromone 1.
Scheme 3
Scheme 3
Asymmetric hydrogenation of 4-chromone 3.
Scheme 4
Scheme 4
Resolution of (±)-flavanone (5) through the synthesis of ketals 6a and 6b.
Scheme 5
Scheme 5
Resolution of (±)-flavanone (5) through conversion into cis-amines 7a and 7b.
Scheme 6
Scheme 6
Enzymatic kinetic resolution of racemic flavanol acetate 9.
Scheme 7
Scheme 7
Enzymatic kinetic resolution of racemic flavanone oxime acetate 10.
Scheme 8
Scheme 8
Lipase-catalyzed kinetic resolution of racemic flavanol 8.
Scheme 9
Scheme 9
Enzymatic resolution of flavanones via Mitsunobu construction of α-phenoxyester 14.
Scheme 10
Scheme 10
Kinetic resolution of 2-substituted 2,3-dihydro-4-quinolones 17 through palladium-catalyzed asymmetric allylic alkylation.
Scheme 11
Scheme 11
Diastereoselective cojugate addition to sulfinylchromone 20.
Scheme 12
Scheme 12
Total synthesis of the originally proposed structure of leridol (25).
Scheme 13
Scheme 13
Highly enantioselective copper-catalyzed conjugate addition of dialkylzinc reagents to 4-chromanone (26).
Scheme 14
Scheme 14
Asymmetric synthesis of 2-aryl-2,3-dihydro-4-quinolones 32 by rhodium-catalyzed 1,4-addition of arylzinc reagents in the presence of chlorotrimethylsilane.
Scheme 15
Scheme 15
Rhodium-catalyzed asymmetric 1,4-additions of sodium tetraarylborates to 4-chromones 33 in the presence of a C2-symmetric chiral bis-sulfoxide ligand.
Scheme 16
Scheme 16
Enantioselective synthesis of flavanones 34 through rhodium-catalyzed 1,4-additions of phenylboronic acid derivatives.
Scheme 17
Scheme 17
Enantioselective synthesis of (S)-pinostrobin (38) through a rhodium-catalyzed 1,4-addition of phenylboronic acid.
Scheme 18
Scheme 18
Quinine-catalyzed stereoselective cyclization of o-tigloylphenol 39.
Scheme 19
Scheme 19
Quinine-catalyzed asymmetric cyclization of 2′,6′-dihydroxychalcone 42.
Scheme 20
Scheme 20
Catalytic enantioselective synthesis of flavanones and chromanones 45 from alkylidenes 44.
Scheme 21
Scheme 21
Total synthesis of flindersiachromanone (47) through a single-flask Knoevenagel condensation/cyclization/decarboxylation sequence.
Scheme 22
Scheme 22
NiII-catalyzed cyclization of alkylidenes 44.
Scheme 23
Scheme 23
Cyclization of alkylidenes 44 catalyzed by chiral N-triflyl phosphoramides.
Scheme 24
Scheme 24
Asymmetric synthesis of 2-aryl-2,3-dihydro-4-quinolones 49 catalyzed by bifunctional thioureas.
Scheme 25
Scheme 25
Tandem intramolecular conjugate addition/decarboxylation reaction sequences from alkylidenes 50.
Scheme 26
Scheme 26
Synthesis of chiral 2-methylchromanone 54.
Scheme 27
Scheme 27
First total synthesis of (–)-pinostrobin (38).
Scheme 28
Scheme 28
Synthesis of (2R)-flavanone (5) through a dithiane addition/intramolecular Mitsunobu inversion sequence.
Scheme 29
Scheme 29
Tandem cyclization/fluorination sequences starting from alkylidenes 61.
Scheme 30
Scheme 30
Tandem intramolecular conjugate addition/Michael addition or halogenation sequences.
Scheme 31
Scheme 31
Oxidative cyclization of 2-(1-hydroxybut-3-en-1-yl)-phenol.

Similar articles

Cited by

References

    1. Andersen ØM, Markham KR. Flavonoids: Chemistry, Biochemistry and Applications. CRC, Taylor & Francis; Boca Raton, FL: 2006.
    1. Evans BE, Rittle KE, Bock MG, Dipardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J. J Med Chem. 1988;31:2235–2246. - PubMed
    1. Veitch NC, Grayer RJ. Nat Prod Rep. 2011;28:1626–1695. - PubMed
    2. Veitch NC, Grayer REJ. Nat Prod Rep. 2008;25:555–611. - PubMed
    3. Williams CA, Grayer RJ. Nat Prod Rep. 2004;21:539–573. - PubMed
    4. Harborne JB, Williams CA. Nat Prod Rep. 2001;18:310–333. - PubMed
    5. Harborne JB, Williams CA. Nat Prod Rep. 1998;15:631–652.
    6. Harborne JB, Williams CA. Nat Prod Rep. 1995;12:639–657.
    7. Crozier A, Jaganath IB, Clifford MN. Nat Prod Rep. 2009;26:1001–1043. - PubMed
    8. Crozier A, Del Rio D, Clifford MN. Mol Aspects Med. 2010;31:446–467. - PubMed
    9. Silva FRMB, Cazarolli LH, Zanatta L, Alberton EH, Figueiredo MSRB, Folador P, Damazio RG, Pizzolatti MG. Mini-Rev Med Chem. 2008;8:1429–1440. - PubMed
    10. Veitch NC. Nat Prod Rep. 2009;26:776–802. - PubMed
    11. Veitch NC. Nat Prod Rep. 2007;24:417–464. - PubMed
    12. Reynaud J, Guilet D, Terreux R, Lussignol M, Walchshofer N. Nat Prod Rep. 2005;22:504–515. - PubMed
    1. Robards K, Tucker G. Crit Rev Food Sci Nutr Crit Rev Food Sci. 2008;48:929–966. - PubMed
    2. Boland GM, Donnelly DMX. Nat Prod Rep. 1998;15:241–260.
    3. Daayf F, Lattanzio V, Santos-Buelga C, Escribano-Bailon MT. Recent Advances in Polyphenol Research. Wiley-Blackwell; Oxford, Ames, Iowa: 2008.
    4. Keller RB. Flavonoids: Biosynthesis, Biological Effects and Dietary Sources. Nova Science Publishers; Hauppauge, NY: 2009.
    5. Huang YB, Du H, Tang YX. Appl Microbiol Biotechnol. 2010;86:1293–1312. - PubMed
    1. Dittmer C, Raabe G, Hintermann L. Eur J Org Chem. 2007:5886–5898.
    2. Wang YC, Chen S, Yu O. Appl Microbiol Biotechnol. 2011;91:949–956. - PubMed

LinkOut - more resources